India’s Central Drugs Standard Control Organisation (CDSCO) has flagged 40 batches of medicines and healthcare products as Not of Standard Quality (NSQ) in its July 2026 surveillance results. The samples failed pharmacopoeial or manufacturer specifications across tests including sterility and
